ProQR Therapeutics NV
NASDAQ:PRQR
ProQR Therapeutics NV
Revenue
ProQR Therapeutics NV
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ProQR Therapeutics NV
NASDAQ:PRQR
|
Revenue
€9.5m
|
CAGR 3-Years
0%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
Pharming Group NV
AEX:PHARM
|
Revenue
$245.3m
|
CAGR 3-Years
5%
|
CAGR 5-Years
11%
|
CAGR 10-Years
43%
|
|
Uniqure NV
NASDAQ:QURE
|
Revenue
$15.8m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
7%
|
CAGR 10-Years
14%
|
|
argenx SE
XBRU:ARGX
|
Revenue
$1.2B
|
CAGR 3-Years
210%
|
CAGR 5-Years
121%
|
CAGR 10-Years
N/A
|
|
Merus NV
NASDAQ:MRUS
|
Revenue
$43.9m
|
CAGR 3-Years
14%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
N
|
NewAmsterdam Pharma Company NV
NASDAQ:NAMS
|
Revenue
€97.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is ProQR Therapeutics NV's Revenue?
Revenue
9.5m
EUR
Based on the financial report for Dec 31, 2023, ProQR Therapeutics NV's Revenue amounts to 9.5m EUR.
What is ProQR Therapeutics NV's Revenue growth rate?
Revenue CAGR 5Y
11%
Over the last year, the Revenue growth was 98%.